Scholarly Works

Use of the Epidermal Growth Factor Receptor...

Journal article

Use of the Epidermal Growth Factor Receptor Inhibitors Gefitinib and Erlotinib in the Treatment of Non-small Cell Lung Cancer: A Systematic Review

Authors

Feld R; Sridhar SS; Shepherd FA; Mackay JA; Evans WK

Journal

Journal of Thoracic Oncology, Vol. 1, No. 4, pp. 367–376

Publisher

Elsevier

Publication Date

January 1, 2006

DOI

10.1097/01243894-200605000-00018

ISSN

1556-0864

Associated Experts

William Evans

Professor Emeritus, Faculty of Health Sciences

Labels

Fields of Research (FoR)

32 Biomedical and Clinical Sciences 3202 Clinical sciences 3211 Oncology and carcinogenesis

Medical Subject Headings (MeSH)

Antineoplastic Combined Chemotherapy Protocols Carcinoma, Non-Small-Cell Lung Dose-Response Relationship, Drug ErbB Receptors Erlotinib Hydrochloride Gefitinib Humans Lung Neoplasms Quality of Life Quinazolines Randomized Controlled Trials as Topic

View published work (Non-McMaster Users)

View published work (McMaster Users)

Contact the Experts team

Get technical help

or

Provide website feedback